www.黄在线看_国产成人午夜精品影院游乐网_国产成人久久av免费高清蜜臀_久久久999久久久_午夜 国产_一区二区三区四区国产

加入收藏 | 設為首頁 | 聯系我們

產品搜索

聯系我們

聯系人:蔣經理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區緯地路9號
Email: zhangxiangwen@cobioer.com

產品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73190BCR-ABL1 T315I/BaF3

BCR-ABL1 T315I/BaF3
名稱 BCR-ABL1 T315I/BaF3
型號 CBP73190
報價
特點 BCR-ABL1 [T315I]/BaF3,母細胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細內容
CBP73190
I. Introduction

Cell Line Name:

BCR-ABL1 [T315I]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

 
II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.
ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.
Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.
The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.
Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.

 
III. Representative Data

1. WB of BCR-ABL1 [T315I]/BaF3


2. Sanger of BCR-ABL1 [T315I]/BaF3


Figure 2. BCR-ABL1 T315I/BaF3 T315I

Figure 3. BCR-ABL1 T315I/BaF3 Fusion

 

3. Anti-proliferation assay

Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 T315I Cells.

如果你對CBP73190BCR-ABL1 T315I/BaF3感興趣,想了解更詳細的產品信息,填寫下表直接與廠家聯系:


留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7

化工儀器網

推薦收藏該企業網站
主站蜘蛛池模板: 日本中文字幕一区二区有码在线 | 天天摸夜夜摸成人免费视频 | 国产高清美女一级毛片久久 | 成人免费播放视频777777 | 日韩美女奶水喂男人在线观看 | 日本黄色一级大片 | 亚洲国产精品久久精品 | 精品视频在线观看一区二区 | 天天射日日操 | 伊人天天操 | 成人精品综合免费视频 | 在线观看免费黄网站 | 国产成人成人一区二区 | 四虎在线免费观看 | 欧美一区二区三区成人看不卡 | 偷拍与自拍 | 日韩a级片视频 | 精品国产麻豆免费人成网站 | 久久无码专区国产精品s | 十八男男在线观看视频 | 91视频香蕉视频 | 欧美久久一区二区三区 | 国产成人av免费观看 | 中文字幕日韩三级片 | 成人满18在线观看网站免费 | 亚洲免费人成在线视频观看 | 在线看片无码永久免费视频 | 亚洲色图久久 | 亚洲欧美成人综合在线 | 国产日韩亚洲欧美 | 一级做a爰片久久毛片欧美 一级做a爰片久久毛片鸭王 | 樱花草在线播放免费中文 | 亚洲欧洲日本在线 | 国产成人综合在线视频 | 亚洲avav天堂av在线网毛片 | 全免费a级毛片免费毛视频 全免费毛片在线播放 | 日韩人妻一区二区三区蜜桃视频 | 男ji大巴进入女人的视频小说 | 大桥久未无码吹潮在线观看 | 精品人妻一区二区三区四区 | 色婷综合 |